The Internal Revenue Service recently spelled out how a 2.3% excise tax on medical devices will be carried out. But manufacturers and other organizations likely to be affected by the new rule want to delay or eliminate its implementation. At press time, many critics said they were hoping a repeal could be folded into an agreement between Congress and the president to avoid the looming “fiscal cliff” of tax increases and spending cuts.